ADENTRA (ADEN) Q3 2024 earnings summary

Executive summary

• Q3 2024 sales rose 1.8% to $568.8 million, with the Woolf acquisition contributing $31.4 million and offsetting a 3.7% decline in organic sales.

• Net income increased 28.7% to $10.4 million, and basic EPS rose 16.7% to $0.42.

• Gross margin improved to 21.3%, supported by strategic initiatives and higher-margin acquisitions.

• Adjusted EBITDA was $48 million, down 7.2% year-over-year, mainly due to increased operating expenses from the Woolf acquisition and inflationary pressures.

• Strong cash flow enabled a leverage ratio of 2.5x and a dividend increase to $0.15 per share for January 2025.

Financial highlights

• Gross profit increased to $121.4 million, with gross margin at 21.3%.

• Operating expenses decreased by $4.2 million to $96.7 million, mainly due to non-recurrence of prior year trade duties.

• Operating cash flow before working capital changes increased to $38.6 million from $25.9 million.

• For the nine months, sales were $1.65 billion, down 4.1% year-over-year, with stable volumes and improved gross margin percentage.

• Net income for nine months grew 40.8% to $38.1 million; adjusted net income up 4.7% to $59.1 million.

Outlook and guidance

• Q4 2024 adjusted EBITDA anticipated to align closely with Q4 2023, despite affordability pressures and slow interest rate reductions.

• Expect solid cash flow in Q4 2024, supporting further debt repayment and M&A activity.

• Destination 2028 plan targets $3.5 billion annual run rate revenue, 10%+ EBITDA margin, and 12%+ ROIC.

• Forecasts indicate improving building market conditions in H2 2025 and beyond, driven by expected interest rate cuts and strong housing fundamentals.